List of works - Maria Roussou

A VR playground for learning abstract mathematics concepts

scientific article published in January 2009

A digital look at physical museum exhibits: Designing personalized stories with handheld Augmented Reality in museums

article

A user-centered approach on combining realism and interactivity in virtual environments

article

A versatile large-scale multimodal VR system for cultural heritage visualization

scholarly article published 2006

Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group

scientific article published on 06 March 2019

Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis

scientific article published on 4 April 2016

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

scientific article published on 27 February 2017

Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients

scientific article published on 03 November 2020

Cell-free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations

scientific article published on 03 April 2020

Children designers in the museum

Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia

scientific article published on 31 March 2018

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction

scientific article published on 03 October 2020

Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens

scientific article published on 24 July 2013

Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis

scientific article

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

scientific article published on 14 April 2020

Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases

Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates

scientific article published on 10 January 2019

Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu

scientific article published on 02 March 2020

Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance

scientific article published on 23 August 2020

Design and Evaluation of a Real-World Virtual Environment for Architecture and Urban Planning

article by George Drettakis et al published June 2007 in Presence: Teleoperators & Virtual Environments

Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies

scientific article published on 19 July 2018

Developing Participatory Methods to Consider the Ethics of Emerging Technologies for Children

scientific article published on 20 April 2023

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenstrom macroglobulinemia: final analysis of a phase 2 study

article

Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients

scientific article published on 28 May 2012

Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis

scientific article published on 01 December 2018

Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM

scientific article published on 23 August 2018

Evaluation of direct manipulation using finger tracking for complex tasks in an immersive cube

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.

scientific article published on 24 May 2018

Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma

scientific article

Exploring activity theory as a tool for evaluating interactivity and learning in virtual environments for children

Exploring rules and underlying concepts while engaged with collaborative full-body games

Expression of CCL3 by Neoplastic Cells in Patients with Waldenström's Macroglobulinemia: An Immunohistochemical Study in Bone Marrow Biopsies of 67 Patients

scientific article published on 01 February 2011

Families and Mobile Devices in Museums

Flow, Staging, Wayfinding, Personalization: Evaluating User Experience with Mobile Museum Narratives

Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy

scientific article published on 11 June 2017

Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis

scientific article published on 31 January 2018

Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens

scientific article

High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients

Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents

scholarly article by Anna Tasidou et al published 6 May 2012 in American Journal of Hematology

Interactivity and conceptual learning in virtual environments for children

Involvement of small nerve fibres and autonomic nervous system in AL amyloidosis: comprehensive characteristics and clinical implications

scientific article published on 23 January 2020

Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment

scientific article published on 20 February 2010

Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma

Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias

scientific article published on 04 August 2011

Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period

scientific article published on 07 May 2020

Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies

scientific article published on 9 March 2015

Moving beyond the virtual museum: Engaging visitors emotionally

Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma

scientific article published on 3 November 2015

Next generation flow cytometry for MRD detection in patients with AL amyloidosis

scientific article published on 12 August 2020

Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström’s macroglobulinemia

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

scientific article published on 01 October 2019

Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial

scientific article published on November 2010

Pulsed cyclophosphamide, thalidomide and dexamethasone regimen for previously treated patients with multiple myeloma: Long term follow up and disease control after subsequent treatments

scientific article published in January 2007

Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens

scientific article

Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy

scientific article published on 28 March 2017

Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause

scientific article published on 27 July 2020

Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents

scientific article published on 01 April 2007

Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents

scientific article published on 26 May 2010

Rituximab-based treatments in Waldenström's macroglobulinemia

scientific article published on March 2009

Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy

Studying Player Experience in a Collaborative Embodied Interaction Game

The CREATE project: mixed reality for design, education, and cultural heritage with a constructivist approach

scholarly article

The Interplay between Form, Story, and History: The Use of Narrative in Cultural and Educational Virtual Reality

The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents

scientific article published on 22 November 2017

The virtual playground: an educational virtual reality environment for evaluating interactivity and conceptual learning

Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis

scientific article published on 27 July 2020

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

scientific article

Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens

scientific article published on May 2008

List of works by Maria Roussou

A VR playground for learning abstract mathematics concepts

A digital look at physical museum exhibits: Designing personalized stories with handheld Augmented Reality in museums

A user-centered approach on combining realism and interactivity in virtual environments

A versatile large-scale multimodal VR system for cultural heritage visualization

Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group

Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis

Cardiac and renal complications of carfilzomib in patients with multiple myeloma

Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients

Cell-free DNA analysis for the detection of MYD88 and CXCR4 mutations in IgM monoclonal gammopathies; an update with clinicopathological correlations

Children designers in the museum

Circulating Soluble Receptor Activator of Nuclear Factor Kappa B Ligand and C-C Motif Ligand 3 Correlate With Survival in Patients With Waldenström Macroglobulinemia

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Induction

Clinical and genetic factors associated with venous thromboembolism in myeloma patients treated with lenalidomide-based regimens

Clinical and prognostic significance of serum levels of von Willebrand factor and ADAMTS-13 antigens in AL amyloidosis

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases

Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates

Consolidation with carfilzomib, lenalidomide, and dexamethasone (KRd) following ASCT results in high rates of minimal residual disease negativity and improves bone metabolism, in the absence of bisphosphonates, among newly diagnosed patients with mu

Daratumumab-based therapy for patients with monoclonal gammopathy of renal significance

Design and Evaluation of a Real-World Virtual Environment for Architecture and Urban Planning

Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies

Developing Participatory Methods to Consider the Ethics of Emerging Technologies for Children

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenstrom macroglobulinemia: final analysis of a phase 2 study

Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients

Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis

Elevated vWF Antigen Serum Levels Are Associated With Poor Prognosis, and Decreased Circulating ADAMTS-13 Antigen Levels Are Associated With Increased IgM Levels and Features of WM but not Increased vWF Levels in Patients With Symptomatic WM

Evaluation of direct manipulation using finger tracking for complex tasks in an immersive cube

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.

Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma

Exploring activity theory as a tool for evaluating interactivity and learning in virtual environments for children

Exploring rules and underlying concepts while engaged with collaborative full-body games

Expression of CCL3 by Neoplastic Cells in Patients with Waldenström's Macroglobulinemia: An Immunohistochemical Study in Bone Marrow Biopsies of 67 Patients

Families and Mobile Devices in Museums

Flow, Staging, Wayfinding, Personalization: Evaluating User Experience with Mobile Museum Narratives

Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy

Growth Differentiation Factor 15 Is a New Biomarker for Survival and Renal Outcomes in Light Chain (AL) Amyloidosis

Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens

High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients

Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents

Interactivity and conceptual learning in virtual environments for children

Involvement of small nerve fibres and autonomic nervous system in AL amyloidosis: comprehensive characteristics and clinical implications

Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment

Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma

Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias

Long PFS of more than 7 years is achieved in 9% of myeloma patients in the era of conventional chemotherapy and of first-generation novel anti-myeloma agents: a single-center experience over 20-year period

Long-term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies

Moving beyond the virtual museum: Engaging visitors emotionally

Neutrophil Gelatinase--Associated Lipocalin and Cystatin C Are Sensitive Markers of Renal Injury in Patients With Multiple Myeloma

Next generation flow cytometry for MRD detection in patients with AL amyloidosis

Phase 2 study of ofatumumab, fludarabine and cyclophosphamide in relapsed/refractory Waldenström’s macroglobulinemia

Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone

Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial

Pulsed cyclophosphamide, thalidomide and dexamethasone regimen for previously treated patients with multiple myeloma: Long term follow up and disease control after subsequent treatments

Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens

Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy

Renal pathology in patients with monoclonal gammopathy or multiple myeloma: monoclonal immunoglobulins are not always the cause

Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents

Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents

Rituximab-based treatments in Waldenström's macroglobulinemia

Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy

Studying Player Experience in a Collaborative Embodied Interaction Game

The CREATE project: mixed reality for design, education, and cultural heritage with a constructivist approach

The Interplay between Form, Story, and History: The Use of Narrative in Cultural and Educational Virtual Reality

The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents

The virtual playground: an educational virtual reality environment for evaluating interactivity and conceptual learning

Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis

Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone

Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens